Dr. Lal PathLabs (BOM:539524) EBITDA Margin % : 32.33% (As of Mar. 2025)

Dr. Lal PathLabs EBITDA Margin % Chart

Dr. Lal PathLabs Annual Data
	Trend	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23	Mar24	Mar25
EBITDA Margin %		Get a 7-Day Free Trial					30.84	29.38	26.36	30.47	32.05

Dr. Lal PathLabs Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EBITDA Margin %	Get a 7-Day Free Trial															29.90	31.67	33.99	30.02	32.33

Competitive Comparison of Dr. Lal PathLabs's EBITDA Margin %

For the Diagnostics & Research subindustry, Dr. Lal PathLabs's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dr. Lal PathLabs's EBITDA Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Dr. Lal PathLabs's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Dr. Lal PathLabs's EBITDA Margin % falls into.

Dr. Lal PathLabs EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Dr. Lal PathLabs's EBITDA Margin % for the fiscal year that ended in Mar. 2025 is calculated as

Dr. Lal PathLabs's EBITDA Margin % for the quarter that ended in Mar. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dr. Lal PathLabs  (BOM:539524) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Dr. Lal PathLabs EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Dr. Lal PathLabs's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Dr. Lal PathLabs Business Description